Markavyuktakshir Nasya for vyanga(melasma) patients for 15 days

An exploratory clinical study to evaluate the efficacy of Markavyukta ksheer Nasya in the management of vyanga - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060205

Enrollment

Registered

2023-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L578- Other skin changes due to chronicexposure to nonionizing radiation Health Condition 2: L55-L59- Radiation-related disorders of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients showing classical signs and symptoms of vyanga like tanu, niruja, shyava mandal on face. 2. Patients of age between 25 to 55 years irrespective of gender, religion and economic status

Exclusion criteria

Exclusion criteria: 1. Vyanga caused due to any known systemic disease like Addison’s disease, Cushing’s syndrome. 2. Vyanga caused since birth like Nevus of Ota 3. Vyanga along with kushta roga 4. Hyper pigmentation caused by known case of tumour like malignant melanoma 5. Pregnant and lactating women 6. Patient’s anarha for nasya karma

Design outcomes

Primary

Measure	Time frame
To Evaluate efficacy of markavyuktakshir nasya in management of vyanga for 15 daysTimepoint: 3 follow ups will be taken on 7th,15th and 21th day and the treatment will be given for 15 days	—

Secondary

Measure	Time frame
To observe the adverse effect if any for 15 daysTimepoint: 15 days study with 3 folow ups 7th, 15th and 21th day	—

Countries

India

Contacts

Public ContactShubhangi maske

Pdeas College of ayurved and research centre nigadi pradhikaran pune

Rikibepournima@gmail.com9762561699

Outcome results